Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 May 21;10:3699–3717. doi: 10.2147/IJN.S81650

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 Qin et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

TGF-β1 expression in the peritoneal tissues after 7 days of treatment, detected by immunohistochemistry.

Notes: High, medium and low dose groups were administered with 10, 5 and 2.5 mg/kg Tan IIA-NPs via tail vein injection, respectively. Representative images (at 200× magnification) of peritoneal tissues that were stained immunohistochemically with anti-TGF-β1 antibody. (A) Blank control group. (B) Control group. (C) Drug-free group. (D) Low-dose group. (E) Medium-dose group. (F) High-dose group. (G) Quantitative assay of OD from five randomly selected fields. The results are presented as mean ± standard deviation (n=5). *P<0.05 compared with blank; ^#P<0.05 compared with control; ^§P<0.05 compared with drug-free NPs.

Abbreviations: NPs, nanoparticles; OD, optic density; TGF-β1, transforming growth factor-β1.

TGF-β1 expression in the peritoneal tissues after 7 days of treatment, detected by immunohistochemistry.

Notes: High, medium and low dose groups were administered with 10, 5 and 2.5 mg/kg Tan IIA-NPs via tail vein injection, respectively. Representative images (at 200× magnification) of peritoneal tissues that were stained immunohistochemically with anti-TGF-β1 antibody. (A) Blank control group. (B) Control group. (C) Drug-free group. (D) Low-dose group. (E) Medium-dose group. (F) High-dose group. (G) Quantitative assay of OD from five randomly selected fields. The results are presented as mean ± standard deviation (n=5). *P<0.05 compared with blank; ^#P<0.05 compared with control; ^§P<0.05 compared with drug-free NPs.

Abbreviations: NPs, nanoparticles; OD, optic density; TGF-β1, transforming growth factor-β1.